Trends in Pharmacological Sciences
ReviewNuclear receptor ligand-binding domains: three-dimensional structures, molecular interactions and pharmacological implications
Section snippets
Allosteric effects induced by agonists
It is well known that ligand binding induces a conformational change in nuclear receptors, and protease digestion and antibody accessibility studies reveal that agonists and antagonists trigger distinct structural alterations of nuclear receptor LBDs. The resolution of the crystal structures of several ligand-free (apo) and ligand-occupied (holo) nuclear receptor LBDs alone or in a complex with co-activator fragments have provided molecular details of the various ligand-induced changes and,
Structural basis of antagonist action
To date, three crystals of nuclear receptor LBDs bound to pure AF-2 antagonists (Fig. 3) have been reported. The structural determination of the ERα LBD in complexes with the selective anti-oestrogens raloxifen16 and 4-hydroxy-tamoxifen12, provided the first structural evidence for the structural basis of antagonism. This principle was recently extended to another subgroup of the nuclear receptor family with the determination of the structure of the retinoic acid receptor α (RARα) LBD bound to
Structural basis for full and partial AF-2 antagonism
In addition to complete antagonists of AF-2 function (e.g.raloxifen and 4-hydroxytamoxifen), AF-2 partial agonists–antagonists (Fig. 3) have been crystallized with the corresponding receptors. All the structures discussed above show a strict correlation between the orientation of the AF-2 helix and their biological activity. However, the ERβ–genistein19 and RXRα–F318A–oleic acid17 LBD structures show that H12 can adopt the antagonist conformation even though the corresponding ligand elicits a
Orphan receptors as new pharmacological targets
Because of its implication in virtually all fundamental physiological functions, the nuclear receptor superfamily offers an exceptional spectrum of targets for the development of therapeutics. In addition, the rapidly growing number of nuclear receptor superfamily members raises the prospects of new targets and new ligands. Indeed, recently, ligands for several of these new nuclear receptors, the so-called orphan receptors1, 22, have been identified. One example are PPARs whose α isotype was
Acknowledgements
We thank Dino Moras and all colleagues of the structural biology group at the IGBMC for sharing unpublished information and instructive discussions. Studies in our laboratory are supported by funds from the INSERM, CNRS, Hôpital Universitaire de Strasbourg (HUS), the Fondation pour la Recherche Médicale, the Ministère de la Recherche et de la Technologie and Bristol-Myers-Squibb.
Glossary
Chemical names
- BMS394 and BMS395:
- R- and S-3-fluoro-4-[2-hydroxy-2-(5,5,8,8-tetramethyl-5,6,7,8,-tetrahydro-naphthalen-2-yl)-acetylamino]-benzoic acid
- BMS614:
- 4-[(4,4-dimethyl-1,2,3,4-tetrahydro-[1, 2′]binaphthalenyl-7-carbonyl)-amino]-benzoic acid
- BMS961:
- racemic mixture of BMS394 and BMS395
- G1262570:
- (2S)-((2-benzoylphenyl)amino)-3-{4-[2-(5-methyl-2-phenyloxazol-4-yl)ethoxy]phenyl} propionic acid
- GW0072:
- (+/−)-(2S, 5S)-4-(4-(4-carboxyphenyl) butyl)-2-heptyl-4-oxo-5-thiazolidine N,N-dibenzylacetamide
- GW2433:
References (60)
Increasing the complexity of coactivation in nuclear receptor signaling
Cell
(1999)Asymmetry in the PPARγ/RXRα crystal structure reveals the molecular basis of heterodimerization among nuclear receptors
Mol. Cell
(2000)Crystal structure of the ligand-binding domain of the human nuclear receptor PPARγ
J. Biol. Chem.
(1998)Molecular recognition of fatty acids by peroxisome proliferator-activated receptors
Mol. Cell
(1999)The structural basis of estrogen receptor/coactivator recognition and the antagonism of this interaction by tamoxifen
Cell
(1998)Crystal structure of a heterodimeric complex of RAR and RXR ligand-binding domains
Mol. Cell
(2000)- et al.
The RXR heterodimers and orphan receptors
Cell
(1995) Terminal differentiation of human breast cancer through PPARγ
Mol. Cell
(1998)- et al.
Nuclear receptor regulation ofcholesterol and bile acid metabolism
Curr. Opin. Biotechnol.
(1999) An orphan nuclear receptor activated by pregnanes defines a novel steroid signaling pathway
Cell
(1998)
Structural basis for engineering of retinoic acid receptor isotype-selective agonists and antagonists
Chem. Biol.
Two distinct actions of retinoid-receptor ligands
Nature
Ligand-independent recruitment of SRC-1 to estrogen receptor β through phosphorylation of activation function AF-1
Mol. Cell
Therapeutic potential of selective modulators of nuclear receptor action
Curr. Opin. Chem. Biol.
Nuclear receptor cofactors as chromatin remodelers
Curr. Opin. Genet. Dev.
A cold-inducible coactivator of nuclear receptors linked to adaptive thermogenesis
Cell
HATsselective synthetic inhibitors of the histone acetyltransferases p300 and PCAF
Mol. Cell
20-epi analogues of 1,25-dihydroxyvitamin D3 are highly potent inducers of DRIP coactivator complex binding to the vitamin D3 receptor
J. Biol. Chem.
The crystal structure of the nuclear receptor for vitamin D bound to its natural ligand
Mol. Cell
Transcription factors 3nuclear receptors
Protein Profile
Nuclear receptor coregulatorscellular and molecular biology
Endocr. Rev.
The coregulator exchange intranscriptional functions of nuclear receptors
Genes Dev.
Crystal structure of the ligand-binding domain of the human nuclear receptor RXR-α
Nature
A canonical structure for the ligand-binding domain of nuclear receptors
Nat. Struct. Biol.
Crystal structure of the human RXRα ligand-binding domain bound to its natural ligand 9-cis retinoic acid
EMBO J.
Ligand binding and co-activator assembly ofthe peroxisome proliferator-activated receptor-γ
Nature
Structure and specificity of nuclear receptor-coactivator interactions
Genes Dev.
A signature motif in transcriptional co-activators mediates binding to nuclear receptors
Nature
Determinants of coactivator LxxLL motif specificity in nuclear receptor transcriptional activation
Genes Dev.
Molecular basis of agonism and antagonism in the oestrogen receptor
Nature
Cited by (405)
Strategies for developing retinoic acid receptor alpha-selective antagonists as novel agents for male contraception
2023, European Journal of Medicinal ChemistryGenomic signaling of vitamin D
2023, SteroidsPPARα alleviates inflammation via inhibiting NF-κB/Rel pathway in Vibrio splendidus challenged Apostichopus japonicus
2023, Fish and Shellfish ImmunologyDevelopment of a strategy to identify and evaluate direct and indirect activators of constitutive androstane receptor in rats
2022, Food and Chemical Toxicology